A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial.Atopic dermatitis is triggered by...
The Kiwi cannabis collaborations continue - this time between two leading players on the New Zealand scene; Medical Kiwi and Puro.The pair have inked...
Canada's MediPharm Labs Inc. has announced subsidiary MediPharm Labs Australia Pty. Ltd has commenced construction of its cannabis oil extraction facility in South Gippsland,...